Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

14 treatments under study, led by Gold Microneedle Treatment

Research Leaders

9 sponsors active, led by CLASSYS Inc.

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
Phase 1/2 (1)

Trial Status

Completed6
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 6 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Gold Microneedle Treatment1
  • Fractional Picosecond Laser Treatment1
  • Control Device1
  • Autologous Human Platelet Lysate1
  • Fractionated Laser Resurfacing1

Active Sponsors

  • CLASSYS Inc.1
  • Topix Pharmaceuticals1
  • Kasiak Research Pvt. Ltd.1
  • Dermapenworld1
  • Northwestern University1

Top Investigators

Related Conditions

  • Acne Scars2
  • Acne Scar1
  • Acne Scars Atrophic1

Activity Timeline